Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults

Cholesterol efflux capacity (CEC) is of interest given its potential relationship with several important clinical conditions including Alzheimer’s disease. The inactivation of the APOE locus in mouse models supports the idea that it is involved in determining the CEC. With that in mind, we examine the impact of the plasma metabolome profile and the APOE genotype on the CEC in cognitively healthy elderly subjects. The study subjects were 144 unrelated healthy individuals. The plasma CEC was determined by exposing cultured mouse macrophages treated with BODIPY-cholesterol to human plasma. The metabolome profile was determined using NMR techniques. Multiple regression was performed to identify the most important predictors of CEC, as well as the NMR features most strongly associated with the APOE genotype. Plasma 3-hydroxybutyrate was the variable most strongly correlated with the CEC (r = 0.365; p = 7.3 × 10−6). Male sex was associated with a stronger CEC (r = −0.326, p = 6.8 × 10−5). Most of the NMR particles associated with the CEC did not correlate with the APOE genotype. The NMR metabolomics results confirmed the APOE genotype to have a huge effect on the concentration of plasma lipoprotein particles as well as those of other molecules including omega-3 fatty acids. In conclusion, the CEC of human plasma was associated with ketone body concentration, sex, and (to a lesser extent) the other features of the plasma lipoprotein profile. The APOE genotype exerted only a weak effect on the CEC via the modulation of the lipoprotein profile. The APOE locus was associated with omega-3 fatty acid levels independent of the plasma cholesterol level.

[1]  Hanjie Zhang,et al.  [Short-chain fatty acid butyrate acid attenuates atherosclerotic plaque formation in apolipoprotein E-knockout mice and the underlying mechanism]. , 2021, Sheng li xue bao : [Acta physiologica Sinica].

[2]  E. Liehn,et al.  Lipid efflux mechanisms, relation to disease and potential therapeutic aspects. , 2020, Advanced drug delivery reviews.

[3]  H. Chui,et al.  ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes , 2019, The Journal of Neuroscience.

[4]  Xingxing Li,et al.  Butyrate protects against high‐fat diet‐induced atherosclerosis via up‐regulating ABCA1 expression in apolipoprotein E‐deficiency mice , 2019, British journal of pharmacology.

[5]  L. Kritharides,et al.  A critical appraisal of the measurement of serum 'cholesterol efflux capacity' and its use as surrogate marker of risk of cardiovascular disease. , 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[6]  Robert A. Hegele,et al.  Variants at the APOE/C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High‐Density Lipoprotein Cholesterol , 2018, Journal of the American Heart Association.

[7]  V. Zannis,et al.  ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity. , 2018, The Biochemical journal.

[8]  L. Kritharides,et al.  Cell-specific production, secretion, and function of apolipoprotein E , 2018, Journal of Molecular Medicine.

[9]  A. Mauleon,et al.  Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results , 2017, Alzheimer's & Dementia.

[10]  H. Scharnagl,et al.  Impact of Endothelial Lipase on Cholesterol Efflux Capacity of Serum and High-density Lipoprotein , 2017, Scientific Reports.

[11]  M. Koschinsky,et al.  Plasminogen promotes cholesterol efflux by the ABCA1 pathway. , 2017, JCI insight.

[12]  Irina Florina Tudorache,et al.  Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features , 2017, Computational and structural biotechnology journal.

[13]  G. Pawelec,et al.  Alteration of high-density lipoprotein functionality in Alzheimer's disease patients. , 2017, Canadian journal of physiology and pharmacology.

[14]  W. M. van der Flier,et al.  Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment , 2016, Molecular Psychiatry.

[15]  A. Mauleon,et al.  FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research Protocols. , 2017, The journal of prevention of Alzheimer's disease.

[16]  P. Giral,et al.  Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis , 2016, Journal of the American Heart Association.

[17]  G. Rebeck,et al.  Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid , 2016, Journal of neuropathology and experimental neurology.

[18]  M. Pirinen,et al.  Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA , 2016, Nature Communications.

[19]  H. Chui,et al.  ABCA1‐Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease , 2016, Journal of the American Heart Association.

[20]  J. Gallacher,et al.  Convergent genetic and expression data implicate immunity in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[21]  J. Yew,et al.  Progress in Lipid Research , 2015 .

[22]  A. Khera,et al.  HDL cholesterol efflux capacity and incident cardiovascular events. , 2014, The New England journal of medicine.

[23]  Lothar A. Blatter,et al.  Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease , 2014, Front. Physiol..

[24]  D. Rader,et al.  Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS. , 2014, The Journal of clinical endocrinology and metabolism.

[25]  Oscar L. Lopez,et al.  Design of a comprehensive Alzheimer’s disease clinic and research center in Spain to meet critical patient and family needs , 2013, Alzheimer's & Dementia.

[26]  S. Nomura,et al.  The E693Δ (Osaka) mutation in amyloid precursor protein potentiates cholesterol‐mediated intracellular amyloid β toxicity via its impaired cholesterol efflux , 2013, Journal of neuroscience research.

[27]  J. Becker,et al.  Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old , 2013, PloS one.

[28]  M. Phillips,et al.  Serum albumin acts as a shuttle to enhance cholesterol efflux from cells[S] , 2013, Journal of Lipid Research.

[29]  R. Bittman,et al.  A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol , 2011, Journal of Lipid Research.

[30]  S. Henderson Ketone bodies as a therapeutic for Alzheimer’s disease , 2008, Neurotherapeutics.

[31]  S. Mañes,et al.  Immunomodulatory and anti-inflammatory activities of statins. , 2009, Endocrine, metabolic & immune disorders drug targets.

[32]  Reino Laatikainen,et al.  High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. , 2009, The Analyst.

[33]  V. Zannis,et al.  Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. , 2007, The Biochemical journal.

[34]  N. Maeda,et al.  Apolipoprotein E4 in Macrophages Enhances Atherogenesis in a Low Density Lipoprotein Receptor-dependent Manner* , 2007, Journal of Biological Chemistry.

[35]  G. Rebeck Cholesterol efflux as a critical component of Alzheimer’s disease pathogenesis , 2007, Journal of Molecular Neuroscience.

[36]  D. Sparks,et al.  Statin therapy in Alzheimer's disease , 2006, Acta neurologica Scandinavica. Supplementum.

[37]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[38]  Leo Breiman,et al.  Technical note: Some properties of splitting criteria , 2004, Machine Learning.

[39]  M. Togo,et al.  Isoform-Dependent Cholesterol Efflux From Macrophages by Apolipoprotein E Is Modulated by Cell Surface Proteoglycans , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[40]  Vicki Olm,et al.  Statin therapy for Alzheimer's disease: will it work? , 2002, Journal of molecular neuroscience : MN.

[41]  B. Hyman,et al.  Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide , 2001, Nature Cell Biology.

[42]  C. Bergmann,et al.  Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Krempf,et al.  Butyrate stimulates ApoA‐IV‐containing lipoprotein secretion in differentiated Caco‐2 cells: Role in cholesterol efflux , 2001, Journal of cellular biochemistry.

[44]  J. Lafrancois,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model Volume 7, Number 4 (2000), pages 321–331 , 2000, Neurobiology of Disease.

[45]  Rong Wang,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.

[46]  L. Laffel Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes , 1999, Diabetes/metabolism research and reviews.

[47]  A. von Eckardstein,et al.  Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  B. Strooper,et al.  Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .